Swedish Orphan Biovitrum AB (publ)

DB:B6E0 Stock Report

Market Cap: €10.3b

Swedish Orphan Biovitrum Balance Sheet Health

Financial Health criteria checks 3/6

Swedish Orphan Biovitrum has a total shareholder equity of SEK37.1B and total debt of SEK17.5B, which brings its debt-to-equity ratio to 47.1%. Its total assets and total liabilities are SEK72.2B and SEK35.1B respectively. Swedish Orphan Biovitrum's EBIT is SEK6.1B making its interest coverage ratio 4.5. It has cash and short-term investments of SEK594.0M.

Key information

47.1%

Debt to equity ratio

SEK 17.47b

Debt

Interest coverage ratio4.5x
CashSEK 594.00m
EquitySEK 37.11b
Total liabilitiesSEK 35.09b
Total assetsSEK 72.20b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: B6E0's short term assets (SEK12.6B) do not cover its short term liabilities (SEK13.9B).

Long Term Liabilities: B6E0's short term assets (SEK12.6B) do not cover its long term liabilities (SEK21.2B).


Debt to Equity History and Analysis

Debt Level: B6E0's net debt to equity ratio (45.5%) is considered high.

Reducing Debt: B6E0's debt to equity ratio has reduced from 55.4% to 47.1% over the past 5 years.

Debt Coverage: B6E0's debt is well covered by operating cash flow (38.1%).

Interest Coverage: B6E0's interest payments on its debt are well covered by EBIT (4.5x coverage).


Balance Sheet


Discover healthy companies